GGrantIndex
← Leaderboards

K. Ulrich Bayer

University Of Colorado Denver

$14,252,411
Attributed
$18,174,470
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,174,470 · 12

By mechanism

R01$15,637,834 · 6
R21$1,113,492 · 3
U01$776,926 · 1
P30$495,308 · 1
R03$150,910 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Calmodulin-Dependent Protein Kinase Ii

Research focus

Calmodulin-Dependent Protein Kinase IiLearningSynaptic PlasticityBrainMemoryMediatingRegulationNeuronsPhosphorylationSynapsesLong-Term PotentiationSignal TransductionMediator Of Activation ProteinImpairmentPreventAlzheimer&AposPathologicProteinsMental DepressionMutant Strains MiceMutationBindingNovel Therapeutic InterventionAffect

Grant awards (53)

CaMKII Holoenzyme Mechanisms in Opposing Forms of Synaptic Plasticity$479,383
R01 · FY2025 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$349,875
R01 · FY2025 · NS · contact PI
CaMKII holoenzyme mechanisms in opposing forms of synaptic plasticity$11,000
R01 · FY2025 · NS · contact PI
CaMKII nitrosylation in the age-related decline of synaptic plasticity$489,545
R01 · FY2024 · AG · contact PI
CaMKII Holoenzyme Mechanisms in Opposing Forms of Synaptic Plasticity$465,003
R01 · FY2024 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$377,088
R01 · FY2024 · NS · contact PI
CaMKII nitrosylation in the age-related decline of synaptic plasticity$489,545
R01 · FY2023 · AG · contact PI
CaMKII Holoenzyme Mechanisms in Opposing Forms of Synaptic Plasticity$479,383
R01 · FY2023 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2023 · NS · contact PI
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction$583,165
R01 · FY2022 · NS
CaMKII nitrosylation in the age-related decline of synaptic plasticity$489,545
R01 · FY2022 · AG · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2022 · NS · contact PI
CaMKII nitrosylation in the age-related decline of synaptic plasticity$236,725
R01 · FY2022 · AG · contact PI
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction$583,165
R01 · FY2021 · NS
CaMKII nitrosylation in the age-related decline of synaptic plasticity$489,545
R01 · FY2021 · AG · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2021 · NS · contact PI
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction$583,165
R01 · FY2020 · NS
CaMKII nitrosylation in the age-related decline of synaptic plasticity$489,545
R01 · FY2020 · AG · contact PI
CaMKII autophosphorylation in opposing directions of synaptic plasticity$337,486
R01 · FY2020 · NS · contact PI
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction$583,165
R01 · FY2019 · NS
CaMKII autophosphorylation in opposing directions of synaptic plasticity$337,486
R01 · FY2019 · NS · contact PI
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction$583,165
R01 · FY2018 · NS
CaMKII autophosphorylation in opposing directions of synaptic plasticity$337,486
R01 · FY2018 · NS · contact PI
CaMKII autophosphorylation in opposing directions of synaptic plasticity$292,345
R01 · FY2018 · NS · contact PI
A strategy for pharmacological treatment of global cerebral ischemia$776,926
U01 · FY2017 · NS · contact PI
CaMKII in global cerebral ischemia$414,386
R01 · FY2017 · NS
CaMKII autophosphorylation in opposing directions of synaptic plasticity$337,486
R01 · FY2017 · NS · contact PI
Restoring synaptic function in Down Syndrome mice$233,250
R21 · FY2017 · NS · contact PI
CaMKII in global cerebral ischemia$414,386
R01 · FY2016 · NS
CaMKII substrate-selection in opposing forms of synaptic plasticity$338,299
R01 · FY2016 · NS · contact PI
Restoring synaptic function in Down Syndrome mice$194,375
R21 · FY2016 · NS · contact PI
CaMKII in global cerebral ischemia$414,164
R01 · FY2015 · NS
CaMKII substrate-selection in opposing forms of synaptic plasticity$338,353
R01 · FY2015 · NS · contact PI
Rocky Mountain Neurological Disorders Core$102,015
P30 · FY2015 · NS · contact PI
CaMKII in global cerebral ischemia$408,703
R01 · FY2014 · NS
CaMKII substrate-selection in opposing forms of synaptic plasticity$333,955
R01 · FY2014 · NS · contact PI
Persistent reversal of addiction behavior by a transient treatment$191,825
R21 · FY2014 · DA · contact PI
Rocky Mountain Neurological Disorders Core$99,565
P30 · FY2014 · NS · contact PI
CaMKII in global cerebral ischemia$411,499
R01 · FY2013 · NS
CaMKII substrate-selection in opposing forms of synaptic plasticity$334,631
R01 · FY2013 · NS · contact PI
Persistent reversal of addiction behavior by a transient treatment$191,268
R21 · FY2013 · DA · contact PI
Rocky Mountain Neurological Disorders Core$96,541
P30 · FY2013 · NS · contact PI
Rocky Mountain Neurological Disorders Core$99,073
P30 · FY2012 · NS · contact PI
Structural and Catalytic Functions of CaMKII in Neurons$326,896
R01 · FY2011 · NS · contact PI
Rocky Mountain Neurological Disorders Core$98,114
P30 · FY2011 · NS · contact PI
Structural and Catalytic Functions of CaMKII in Neurons$330,343
R01 · FY2010 · NS · contact PI
Structural and Catalytic Functions of CaMKII in Neurons$333,788
R01 · FY2009 · NS · contact PI
Structural and Catalytic Functions of CaMKII in Neurons$333,892
R01 · FY2008 · NS · contact PI
Structural and Catalytic Functions of CaMKII in Neurons$333,993
R01 · FY2007 · NS · contact PI
CaMKII signaling in insulin secretion and response$149,152
R21 · FY2007 · DK · contact PI
CaMKII signaling in insulin secretion and response$153,622
R21 · FY2006 · DK · contact PI
Cell-permeable inibitors specific for CaMKII$74,558
R03 · FY2006 · NS · contact PI
Cell-permeable inibitors specific for CaMKII$76,352
R03 · FY2005 · NS